Marinus Pharma Raises $20 Million
Marinus Pharmaceuticals Inc., a Branford, Conn.-based developer of neurological and psychiatric drugs, has raised $20 million in Series B funding. Return backers include Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners. The company's lead candidate is for adults who suffer from partial onset seizures.
10 April 2009•5 mins read
